Cellular Nucleotide Metabolism in HIV Restriction
HIV 限制中的细胞核苷酸代谢
基本信息
- 批准号:9057577
- 负责人:
- 金额:$ 38.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:ADAR1AddressAllelesAntigen PresentationAntiviral AgentsAntiviral ResponseAutoimmune DiseasesAutoimmunityBindingBiochemicalBiochemical GeneticsBiochemistryBiological AssayCell LineageCellsChemicalsChronicComplexDefense MechanismsDegradation PathwayEnzymesFamilyGap JunctionsGenesGeneticGleanGoalsHIVHIV InfectionsHealthHomeostasisHumanHydrolaseImmune responseImmune systemInfectionInflammationIntegration Host FactorsInterferonsIonsMediatingMethodsMutationMyelogenousMyeloid CellsNatural ImmunityNeurodegenerative DisordersNucleic AcidsNucleotidesPathogenesisPrimatesRecombinantsRegulationReverse TranscriptionRibonucleasesRoentgen RaysRoleSeriesSpecificityStagingStructural BiochemistryStructureSubstrate SpecificitySymptomsSyndromeSystemTREX1 geneVariantViralViral AntigensViral Load resultVirus DiseasesWorkadaptive immunitycell typedeoxyguanosine triphosphatedivalent metalexperienceimmune activationinhibitor/antagonistinnovationinsightlupus-likemutantnovelnucleic acid metabolismnucleotide metabolismpathogenprotein functionpseudotoxoplasmosis syndromeresearch studyresponsescreeningstructural biologytherapeutic targetvif Gene Productsvpr Gene Products
项目摘要
DESCRIPTION (provided by applicant): Our long-term goal is to understand how host factors function in human cells at the interface of maintaining nucleotide homeostasis and initiating viral
defense mechanisms. The battle between viral pathogens like HIV and the primate immune system has placed nucleic acid metabolism center stage. For example, the restriction factors SAMHD1 and APOBEC3D/F/G/H dominantly interfere with HIV replication and are counteracted by viral Vpx and Vif proteins, respectively. Mutations in the SAMHD1 gene cause the autoimmune disease Aicardi-Goutieres syndrome (AGS), a lupus-like neurodegenerative disorder that clinically mimics congenital viral infection. Key insights into the interferon-mediatd innate immune response to nucleic acids have been gleaned from the genetics of AGS. AGS is caused by variations in the nucleic acid metabolizing enzymes SAMHD1, TREX1, the three-subunit RNase H2 complex, and ADAR1. Our work on the biochemistry and structure of SAMHD1 revealed the deoxynucleotide triphosphohydrolase activity and suggested a mechanism by which this enzyme might function at the interface of nucleic acid metabolism and the interferon-mediated antiviral response, serving normally to regulate cellular dNTP levels and during an interferon response to starve HIV of dNTPs required for reverse transcription. However, the details of the mechanism of SAMHD1 action in human cells and in HIV pathogenesis during immune activation are not well understood. In particular, the mechanisms by which this enzyme is regulated and how dysfunctional variants of SAMHD1 trigger nucleic acid-mediated innate immune responses and autoimmune disease have not been defined. In this project we will perform biochemical, genetic, and structural studies to generate a comprehensive understanding of SAMHD1 and its roles in nucleic acid metabolism, antiviral defense, and autoimmunity. Insights into these mechanisms will uncover new opportunities for therapeutic targeting in the antiviral response, autoimmunity, and inflammation.
描述(由申请人提供):我们的长期目标是了解人类细胞中宿主因子如何在维持核苷酸稳态和启动病毒的界面上发挥作用
防御机制。 HIV等病毒病原体与灵长类动物免疫系统之间的战斗已将核酸代谢置于中心舞台。例如,限制因子 SAMHD1 和 APOBEC3D/F/G/H 主要干扰 HIV 复制,并分别被病毒 Vpx 和 Vif 蛋白抵消。 SAMHD1 基因突变会导致自身免疫性疾病 Aicardi-Goutieres 综合征 (AGS),这是一种类似狼疮的神经退行性疾病,临床上类似于先天性病毒感染。关于干扰素介导的核酸先天免疫反应的关键见解是从 AGS 遗传学中收集到的。 AGS 是由核酸代谢酶 SAMHD1、TREX1、三亚基 RNase H2 复合物和 ADAR1 的变异引起的。我们对 SAMHD1 的生物化学和结构的研究揭示了脱氧核苷酸三磷酸水解酶的活性,并提出了一种机制,该酶可能在核酸代谢和干扰素介导的抗病毒反应的界面上发挥作用,正常情况下调节细胞 dNTP 水平,并在干扰素反应期间使 HIV 缺乏逆转录所需的 dNTP。然而,SAMHD1 在人体细胞和免疫激活过程中 HIV 发病机制中的作用机制细节尚不清楚。特别是,这种酶的调节机制以及 SAMHD1 的功能失调变体如何触发核酸介导的先天免疫反应和自身免疫性疾病尚未明确。在这个项目中,我们将进行生化、遗传学和结构研究,以全面了解 SAMHD1 及其在核酸代谢、抗病毒防御和自身免疫中的作用。对这些机制的深入了解将揭示抗病毒反应、自身免疫和炎症治疗靶向的新机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRED W PERRINO其他文献
FRED W PERRINO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRED W PERRINO', 18)}}的其他基金
Cellular Nucleotide Metabolism in HIV Restriction
HIV 限制中的细胞核苷酸代谢
- 批准号:
8658575 - 财政年份:2014
- 资助金额:
$ 38.31万 - 项目类别:
Mechanisms of the 3'-->5' deoxyribonucleases
3-->5 脱氧核糖核酸酶的机制
- 批准号:
7885067 - 财政年份:2009
- 资助金额:
$ 38.31万 - 项目类别:
Mechanisms of the 3'-->5' deoxyribonucleases
3-->5 脱氧核糖核酸酶的机制
- 批准号:
8245781 - 财政年份:2004
- 资助金额:
$ 38.31万 - 项目类别:
Mechanisms of the 3'-->5' deoxyribonucleases
3-->5 脱氧核糖核酸酶的机制
- 批准号:
7651683 - 财政年份:2004
- 资助金额:
$ 38.31万 - 项目类别:
Mechanisms of the 3'-->5' deoxyribonucleases
3-->5 脱氧核糖核酸酶的机制
- 批准号:
8054272 - 财政年份:2004
- 资助金额:
$ 38.31万 - 项目类别:
EXONUCLEASE IN THERAPEUTIC RESISTANCE TO ANTITUMOR DRUGS
核酸外切酶在抗肿瘤药物治疗耐药中的作用
- 批准号:
6489107 - 财政年份:1999
- 资助金额:
$ 38.31万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.31万 - 项目类别:
Research Grant














{{item.name}}会员




